Login / Signup

Elevated serum level of B-cell activating factor (BAFF) after rituximab therapy in pemphigus vulgaris patients suggests a possible therapeutic efficacy of B-cell depletion therapies combined with anti-BAFF agents.

Elham DaneshvarSoheil TavakolpourHamidreza MahmoudiMaryam DanespazhoohAmir TeimourpourSaeed AslaniKamran Balighi
Published in: International journal of dermatology (2022)
Elevated BAFF in the sera could be associated with PV immunopathogenesis. Inhibition of BAFF after rituximab therapy might interfere with repopulation of B cells and confer a therapeutic approach in PV.
Keyphrases